Why Elutia Shares Are Trading Higher By Around 55%; Here Are 20 Stocks Moving Premarket
Portfolio Pulse from Lisa Levin
Shares of several companies including Connexa Sports Technologies, Elutia, Galera Therapeutics, Senti Biosciences, Neptune Wellness Solutions, Aclarion, Cybin, Avinger, SelectQuote, and Bit Brother Limited are trading higher in pre-market. Elutia's shares rose after the sale of its Orthobiologics business unit to Berkeley Biologics. Galera scheduled a meeting with the FDA to discuss next steps for its radiotherapy avasopasem. Neptune Wellness announced intention to spinout Sprout Organics. Cybin shares surged after hedge fund owner Steve Cohen invested $19 million in the company. On the other hand, shares of Digital Transformation Opportunities Corp., Rocket Lab USA, Novo Integrated Sciences, 60 Degrees Pharmaceuticals, Terran Orbital Corporation, Perspective Therapeutics, MSP Recovery, T2 Biosystems, SCWorx Corp., and FLJ Group Limited are trading lower in pre-market.
September 19, 2023 | 11:59 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Aclarion shares jumped in pre-market trading after falling 12% on Monday.
The jump in Aclarion's shares in pre-market trading could lead to a positive short-term impact on its stock price.
CONFIDENCE 100
IMPORTANCE 50
RELEVANCE 100
POSITIVE IMPACT
Avinger shares climbed in pre-market trading after the company announced the commercial launch of its Tigereye ST image-guided CTO crossing device.
The commercial launch of Avinger's Tigereye ST image-guided CTO crossing device could lead to a positive short-term impact on its stock price.
CONFIDENCE 100
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Bit Brother Limited shares gained in pre-market trading.
The gain in Bit Brother Limited's shares in pre-market trading could lead to a positive short-term impact on its stock price.
CONFIDENCE 100
IMPORTANCE 50
RELEVANCE 100
POSITIVE IMPACT
Connexa Sports Technologies shares rose 73.5% in pre-market trading after falling 15% on Monday.
The rise in Connexa's shares in pre-market trading could lead to a positive short-term impact on its stock price.
CONFIDENCE 100
IMPORTANCE 50
RELEVANCE 100
POSITIVE IMPACT
Cybin shares surged after hedge fund owner Steve Cohen invested $19 million in the company.
The investment of $19 million in Cybin by hedge fund owner Steve Cohen could lead to a positive short-term impact on its stock price.
CONFIDENCE 100
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Elutia's shares rose after the company announced the sale of its Orthobiologics business unit to Berkeley Biologics.
The sale of Elutia's Orthobiologics business unit to Berkeley Biologics could lead to a positive short-term impact on its stock price.
CONFIDENCE 100
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Galera Therapeutics shares rose as the company scheduled a meeting with the FDA to discuss next steps for its radiotherapy avasopasem.
The scheduled meeting with the FDA to discuss next steps for Galera's radiotherapy avasopasem could lead to a positive short-term impact on its stock price.
CONFIDENCE 100
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Neptune Wellness shares rose in pre-market trading after the company announced intention to spinout Sprout Organics.
The announcement of Neptune Wellness' intention to spinout Sprout Organics could lead to a positive short-term impact on its stock price.
CONFIDENCE 100
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
SelectQuote shares rose in pre-market trading after COO William Grant, III reported purchase of 150,000 shares.
The purchase of 150,000 shares of SelectQuote by COO William Grant, III could lead to a positive short-term impact on its stock price.
CONFIDENCE 100
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Senti Biosciences shares gained in pre-market trading after dipping around 17% on Monday.
The gain in Senti Biosciences' shares in pre-market trading could lead to a positive short-term impact on its stock price.
CONFIDENCE 100
IMPORTANCE 50
RELEVANCE 100
NEGATIVE IMPACT
Perspective Therapeutics shares fell in pre-market trading after jumping 56% on Monday.
The fall in Perspective Therapeutics' shares in pre-market trading could lead to a negative short-term impact on its stock price.
CONFIDENCE 100
IMPORTANCE 50
RELEVANCE 100
NEGATIVE IMPACT
Digital Transformation Opportunities Corp. shares fell in pre-market trading after jumping 173% on Monday.
The fall in Digital Transformation Opportunities Corp.'s shares in pre-market trading could lead to a negative short-term impact on its stock price.
CONFIDENCE 100
IMPORTANCE 50
RELEVANCE 100
NEGATIVE IMPACT
FLJ Group Limited shares fell in pre-market trading after declining 6% on Monday.
The fall in FLJ Group Limited's shares in pre-market trading could lead to a negative short-term impact on its stock price.
CONFIDENCE 100
IMPORTANCE 50
RELEVANCE 100
NEGATIVE IMPACT
MSP Recovery shares fell in pre-market trading after dipping 35% on Monday.
The fall in MSP Recovery's shares in pre-market trading could lead to a negative short-term impact on its stock price.
CONFIDENCE 100
IMPORTANCE 50
RELEVANCE 100
NEGATIVE IMPACT
Terran Orbital Corporation shares fell in pre-market trading after the company priced its previously announced public offering of shares and warrants.
The pricing of Terran Orbital Corporation's previously announced public offering of shares and warrants could lead to a negative short-term impact on its stock price.
CONFIDENCE 100
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Novo Integrated Sciences shares fell in pre-market trading after declining 15% on Monday.
The fall in Novo Integrated Sciences' shares in pre-market trading could lead to a negative short-term impact on its stock price.
CONFIDENCE 100
IMPORTANCE 50
RELEVANCE 100
NEGATIVE IMPACT
Rocket Lab USA shares fell in pre-market trading as the company's 41st mission succumbs to technical issues, prompting it to postpone its next mission and revise its third-quarter guidance.
The technical issues with Rocket Lab USA's 41st mission and the subsequent postponement of its next mission and revision of its third-quarter guidance could lead to a negative short-term impact on its stock price.
CONFIDENCE 100
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
60 Degrees Pharmaceuticals shares fell in pre-market trading after the company said it has withdrawn its COVID Phase IIB investigational new drug and announced plans to resubmit pending assessment of ability to meet FDA requirements.
The withdrawal of 60 Degrees Pharmaceuticals' COVID Phase IIB investigational new drug and the announcement of plans to resubmit pending assessment of ability to meet FDA requirements could lead to a negative short-term impact on its stock price.
CONFIDENCE 100
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
T2 Biosystems shares fell in pre-market trading after the FDA cleared the company's biothreat panel for commercial distribution.
Despite the FDA clearance for T2 Biosystems' biothreat panel for commercial distribution, its shares fell in pre-market trading, which could lead to a negative short-term impact on its stock price.
CONFIDENCE 100
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
SCWorx Corp. shares fell in pre-market trading after jumping 38% on Monday.
The fall in SCWorx Corp.'s shares in pre-market trading could lead to a negative short-term impact on its stock price.
CONFIDENCE 100
IMPORTANCE 50
RELEVANCE 100